Six weeks before Valeant Pharmaceuticals revealed plans to reorganize and pay down debt, similar ideas to improve the drugmaker’s fortunes were discussed at a private shareholder dinner attended by top investor and board member William Ackman, according to a source who participated. Bank of America hosted the June 29 event, billed as Valeant: a Bull/Bear...
read more
Source: New York Post